STAA

STAA

USD

STAAR Surgical Company Common Stock

$25.280+0.070 (0.278%)

Цена в режиме реального времени

Healthcare
Medical Instruments & Supplies
Соединенные Штаты

График цен

Loading Chart...

Ключевые показатели

Рыночные показатели
Фундаментальные показатели компании
Статистические данные торговли

Рыночные показатели

Открытие

$25.210

Максимум

$25.570

Минимум

$24.610

Объем

1.00M

Фундаментальные показатели компании

Рыночная капитализация

1.2B

Отрасль

Medical Instruments & Supplies

Страна

United States

Статистические данные торговли

Средний объем

1.12M

Биржа

NGM

Валюта

USD

52-недельный диапазон

Минимум $13.5Текущая $25.280Максимум $32

Связанные новости

BusinessWire

Broadwood Partners Condemns Alcon's Fallacious Attacks on STAAR Surgical and Its Prospects

Reminds STAAR's Board That It Does Not Need Alcon's Permission to Remain Independent or Run a Proper Strategic Alternatives Process Broadwood Partners, L.P. and its affiliates ("Broadwood" or "we") today commented on

Просмотреть больше
Broadwood Partners Condemns Alcon's Fallacious Attacks on STAAR Surgical and Its Prospects
BusinessWire

Alcon Releases Investor Discussion Materials Reinforcing Certain Value of Merger Proposal for STAAR Stockholders

Alcon (SIX/NYSE:ALC), the global leader in eye care, today announced that it has filed an investor presentation in support of the proposed acquisition of STAAR Surgical Company (NASDAQ:STAA) with the U.S. Securities and

Просмотреть больше
Alcon Releases Investor Discussion Materials Reinforcing Certain Value of Merger Proposal for STAAR Stockholders
BusinessWire

Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon

Questions Company's Adjournment and Postponement of the Special Meeting Without Substantive Explanation STAAR Should Heed the Strong Shareholder Opposition Already Expressed Through the Special Meeting Voting

Просмотреть больше
Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon
BusinessWire

Yunqi Capital Issues Letter to STAAR Surgical Board Opposing Adjournment of the Special Meeting and Calling for the Company to Move Beyond the Proposed Merger with Alcon

STAAR Should Not Delay the Inevitable and Should Let Shareholders Vote Company Should Not Commence a New "Go Shop" Period or Run a Rushed Sales Process Yunqi Capital Limited (together with its affiliates and the

Просмотреть больше
Yunqi Capital Issues Letter to STAAR Surgical Board Opposing Adjournment of the Special Meeting and Calling for the Company to Move Beyond the Proposed Merger with Alcon
BusinessWire

Broadwood Partners Condemns Decision by STAAR Surgical and Alcon to Delay Final Vote on Proposed Transaction

Appalled that STAAR's Board Reneged on Its Promise to Let Shareholders Decide the Fate of the Proposed Transaction in a Timely Manner Urges STAAR to Give Up on Misbegotten Transaction and Refocus on Running the

Просмотреть больше
Broadwood Partners Condemns Decision by STAAR Surgical and Alcon to Delay Final Vote on Proposed Transaction
BusinessWire

Alcon and STAAR Surgical Announce Adjournment of STAAR Special Meeting of Stockholders

Alcon (SIX/NYSE:ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ:STAA), the manufacturer of the Implantable Collamer® Lens (ICL), today announced

BusinessWire

Broadwood Partners Intends to Call Special Meeting to Remove Several STAAR Surgical Directors

Cautions Board Against Taking Any Substantive or Procedural Action on Alcon Transaction or Delaying Shareholder Vote Calls for Board Refresh to Rebuild Shareholder Trust After Deeply Flawed Sales Process Broadwood

Оставаться в курсе

Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.